Back to results
US 2008/0306070 A1Published application
Combination Therapy Comprising Substituted Oxazolidinones for the Prevention and Treatment of Cerebral Circulatory Disorders
AssigneeBayer HealthCare LLC
InventorsElisabeth Perzborn, Thomas Krahn
Life of this patent
Estimating the term…
Abstract
The present invention relates to combinations of A) oxazolidinones of the formula (I), with B) antiarrhythmics, processes for the production of these combinations, their use for the prophylaxis and/or treatment of diseases, and their use for the manufacture of medicaments for the prophylaxis and/or treatment of diseases, especially of thromboembolic disorders and/or complications.
Claims11
1-10. (canceled)
A combination comprising
- A) a compound of the formula (I)
- in which
- R1 is 2-thiophene which is substituted in position 5 by a radical from the group of chlorine, bromine, methyl or trifluoromethyl,
- R2 is D-A-:
- where:
- the radical “A” is phenylene;
- the radical “D” is a saturated 5- or 6-membered heterocycle which is linked via a nitrogen atom to “A”,
- which has a carbonyl group in direct vicinity to the linking nitrogen atom, and in which a ring carbon member may be replaced by a heteroatom from the series S, N and O;
- where
- the group “A” defined above may optionally be substituted once or twice in the meta position relative to the linkage to the oxazolidinone by a radical from the group of fluorine, chlorine, nitro, amino, trifluoromethyl, methyl or cyano,
- R3, R4, R5, R6, R7 and R8 are hydrogen,
- or one of the salts, solvates and solvates of the salts thereof and
- B) an antiarrhythmic.
10 more elements
Dependencies are inferred from the claim text.